Masimo launches Rad-97

#Masimo (NASDAQ: MASI) announced has launched the #Rad-97™ Pulse-CO Oximeter®* and Next Generation #SedLine®* Brain Function Monitoring in India.

Making the announcement on January 2, 2017 in Bangalore, #Joe Kiani, Founder and CEO of Masimo, said “The Indian healthcare sector recognizes the need for technologies that help their clinicians get the best results, the first time.”

“Masimo’s noninvasive patient monitoring technology innovations offer capabilities that have never been possible before. With a large population and a burgeoning demand for an improved quality of life – including the safe, high-quality healthcare to which all are entitled – India continues to be a focus market for Masimo,” he said at a roundtable of the CEOs of top #Bangalore hospitals.

“We will continue to invest in India and strive to make our technologies and products as accessible as possible, as evidenced by the new Rad-97 and Next Generation SedLine,” he said.

#Bharat Monteiro, Masimo Country Manager for India, noted, “Masimo is committed to doing what is best for patient care in India. In the course of our engagement with leading Indian hospitals, we have witnessed an increased awareness of and commitment to patient safety requirements.”

“Medical providers across the country are eager to adopt advanced technologies and monitoring devices, such as Rad-97 and Next Generation SedLine, which we hope will help provide access to better healthcare, at lower cost,” said Monteiro.

#Dr. Ashutosh Raghuvanshi, Managing Director and Group CEO of #Narayana Health Hospitals, one of the participants in the roundtable, commented, “We constantly endeavor to improve the facilities at our hospitals to ensure better patient care and treatment outcomes.

“With the newly launched Rad-97, we will be able to use Masimo SET® pulse oximetry in more care areas, including ward monitoring, which will help facilitate better monitoring and patient treatment.

Narayana Health performs the highest number of cardiac surgeries in India, and I believe that noninvasive hemoglobin (SpHb) will add immense value to complex cardiac surgeries, helping us reduce unwarranted transfusions and the risk of infection,” said Dr Raghuvanshi.

Rad-97 features Measure-through Motion and Low Perfusion™ SET® pulse oximetry, which studies have shown helps clinicians reduce severe retinopathy of prematurity in neonates, improve CCHD screening in newborns, and, when used for continuous monitoring in post-surgical wards, reduce rapid response activations and costs.

SedLine features four simultaneous EEG leads to enable continuous assessment of both sides of the brain, as well as a Density Spectral Array (DSA), an easy-to-interpret, high-resolution display of bi-hemispheric activity. fii-news.com